Acute exacerbation of idiopathic pulmonary fibrosis after pandemic influenza a (H1N1) vaccination

Internal Medicine

Volumn 49, Issue 21, 2010, Pages 2333-2336

  Umeda, Yukihiro ^a   Morikawa, Miwa ^a   Anzai, Masaki ^a   Sumida, Yasuyuki ^a   Kadowaki, Maiko ^a   Ameshima, Shingo ^a   Ishizaki, Takeshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Acute exacerbation; Adverse event; H1N1; Idiopathic pulmonary fibrosis; Influenza vaccination

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INFLUENZA VACCINE; LACTATE DEHYDROGENASE; MEROPENEM; METHYLPREDNISOLONE; POLYMYXIN B; PREDNISOLONE; SIVELESTAT;

ADULT; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS ANALYSIS; BODY TEMPERATURE; CASE REPORT; DISEASE EXACERBATION; DRUG PULSE THERAPY; FIBROSING ALVEOLITIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERTENSION; HYPOCAPNIA; HYPOXIA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LEUKOCYTE COUNT; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MALE; PANDEMIC INFLUENZA; PULSE RATE; THORAX RADIOGRAPHY; VITAL CAPACITY;

ACUTE DISEASE; DISEASE PROGRESSION; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; MALE; MIDDLE AGED;

EID: 78249260884     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3890     Document Type: Article

References (14)

1. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 331: 778- 784, 1994.
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
3. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176: 636-643, 2007.
4. Holvast B, Huckriede A, Kallenberg CG, Bijl M. Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6: 300-305, 2007.
5. Conti F, Rezai S, Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 8: 124-128, 2008.
6. Vainer-Mossel ED, Mekori YA, Mor A. Ischemic stroke in a patient with lupus following influenza vaccination: a questionable association. Isr Med Assoc J 11: 186-187, 2009.
7. Uji M, Matsushita H, Iwata S. Microscopic polyangiitis after influenza vaccination. Intern Med 44: 892-896, 2005.
8. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathologic findings in three cases. Chest 103: 1808-1812, 1993.
9. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 27: 143-150, 2006.
10. Utz JP, Ryu JH, Douglas WW, et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 17: 175-179, 2001.
11. de Boer T, van Dissel JT, Kuijpers TW, Rimmelzwaan GF, Kroon FP, Ottenhoff TH. Influenza virus vaccination induces interleukin- 12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I. Clin Vaccine Immunol 15: 1171-1175, 2008.
12. Carty CL, Heagerty P, Nakayama K, et al. Inflammatory response after influenza vaccination in men with and without carotid artery disease. Arterioscler Thromb Vasc Biol 26: 2738-2744, 2006.
13. Japanese Ministry of Health, Labour and Welfare. Available at http://www.mhlw.go.jp/shingi/2010/03/s0312-12.html(in Japanese). Accessed April 1, 2010.
14. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 361: 2405-2413, 2009.